Results 91 to 100 of about 4,764 (176)

Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial.

JACC. Heart failure
Although beta-blockers are not recommended for the treatment of heart failure with preserved ejection fraction (HFpEF) according to the latest European Society of Cardiology and American Heart Association/American College of Cardiology/Heart Failure Society of America guidelines, these therapies remain commonly used for comorbidity management.
Peikert, Alexander, Bart, Bradley A., Vaduganathan, Muthiah, Claggett, Brian L., Kulac, Ian J., Kosiborod, Mikhail N., Desai, Akshay S., Jhund, Pardeep S., Lam, Carolyn S.P., Inzucchi, Silvio E., Martinez, Felipe A., de Boer, Rudolf A., Hernandez, Adrian F., Shah, Sanjiv J., Petersson, Magnus, Langkilde, Anna Maria, McMurray, John J.V., Solomon, Scott D., Vardeny, Orly   +18 more
openaire   +3 more sources

Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat. [PDF]

Pharmacol Res Perspect
Sunnåker M, Leander J, Ericsson H.
europepmc   +1 more source

The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions. [PDF]

Front Cardiovasc Med
Ma X, Wang F, Liu D, Li Y, Xia P, Xu Y, Xia H, Peng Y, Chen L.   +8 more
europepmc   +1 more source

The Factors Associated With Readmission in One Year Among Patients With Chronic Heart Failure: A Retrospective Cohort Study. [PDF]

Cureus
Feng Z, Mengyuan H, Lin C, Lisha L, Qiao L, Jing L, Liqin L.   +6 more
europepmc   +1 more source

Beyond Breathlessness Intensity: A Prospective Psychometric Validation of the Multidimensional Dyspnea Profile in Heart Failure with Reduced and Mildly Reduced Ejection Fraction. [PDF]

J Clin Med
Aldhahi MI, Nazer RI, Albarrati AM.
europepmc   +1 more source

Risk of Stroke, Thromboembolism and Mortality in Atrial Fibrillation Patients Across Different Stages and Types of Heart Failure: A Retrospective Cohort Study. [PDF]

J Clin Med
Gao Q, Wang Y, Zhao Y, She F, Lv C, Liu L, Liu P, Liu Y, He R, Liu F, Lv T, Zhang P.   +11 more
europepmc   +1 more source

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review. [PDF]

Heart Fail Rev
Van Spall HGC, Vardeny O.
europepmc   +1 more source

Association Between Heart Failure Ejection Fraction Phenotypes and Contrast-Associated Acute Kidney Injury: A Systematic Review. [PDF]

Cureus
Mohanraj K, Amerson J, Punchayil Narayanankutty N.   +2 more
europepmc   +1 more source

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF

Journal of the American College of Cardiology
Mingming Yang, Alasdair D. Henderson, Atefeh Talebi, John J. Atherton, Chern-En Chiang, Vijay Chopra, Josep Comin-Colet, Mikhail N. Kosiborod, Jose F. Kerr Saraiva, Brian L. Claggett, Akshay S. Desai, Peter Kolkhof, Prabhakar Viswanathan, Andrea Lage, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Katja Rohwedder, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray   +24 more
openaire   +1 more source

Factors Associated with Atrial Fibrillation in Heart Failure with Preserved and Mildly Reduced Ejection Fraction: A Real-World Cohort Study. [PDF]

J Clin Med
Minchev M, Gruev I, Naydenov S.
europepmc   +1 more source